▶ 調査レポート

リュープロレリン酢酸塩の世界市場レポート2020

• 英文タイトル:Covid-19 Impact on Global Leuprorelin Acetate Sales Market Report 2020

Covid-19 Impact on Global Leuprorelin Acetate Sales Market Report 2020「リュープロレリン酢酸塩の世界市場レポート2020」(市場規模、市場予測)調査レポートです。• レポートコード:20QY06-04325
• 出版社/出版日:QYResearch / 2020年6月2日
• レポート形態:英文、PDF、137ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥552,000 (USD4,000)▷ お問い合わせ
  Multi User¥828,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,104,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、リュープロレリン酢酸塩のグローバル市場について種類別(1.88mg製剤、2.75mg製剤、3.75mg製剤)、用途別(病院、クリニック、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・リュープロレリン酢酸塩市場の概要
・世界の主要地域別リュープロレリン酢酸塩市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のリュープロレリン酢酸塩市場規模2015-2026:種類別(1.88mg製剤、2.75mg製剤、3.75mg製剤)
・世界のリュープロレリン酢酸塩市場規模2015-2026:用途別(病院、クリニック、その他)
・リュープロレリン酢酸塩の北米市場規模2015-2020
・リュープロレリン酢酸塩のヨーロッパ市場規模2015-2020
・リュープロレリン酢酸塩の中国市場規模2015-2020
・リュープロレリン酢酸塩の日本市場規模2015-2020
・リュープロレリン酢酸塩の東南アジア市場規模2015-2020
・リュープロレリン酢酸塩のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Merck、Takeda、MediGene、Livzon Pharmaceutical Group、Bejing Biote Pharmaceutical)
・リュープロレリン酢酸塩の製造コスト分析
・販売チャネル、流通業者、顧客
・リュープロレリン酢酸塩の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Leuprorelin Acetate Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Leuprorelin Acetate market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Leuprolide acetate is a synthetic nine – peptide analogue of gonadotropin – releasing hormone. Leuprolide acetate is also known as Leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, and early puberty. It is given by injection into a muscle or under the skin.It is used to treat hormone-reactive cancers, such as prostate and breast cancer.It can also be used for estrogen-dependent conditions, such as endometriosis or uterine fibroids.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Leuprorelin Acetate market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Leuprorelin Acetate industry.
Based on our recent survey, we have several different scenarios about the Leuprorelin Acetate YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Leuprorelin Acetate will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Leuprorelin Acetate market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Leuprorelin Acetate market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Leuprorelin Acetate market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Leuprorelin Acetate market. The report also includes nautical information, where it shows Leuprorelin Acetate market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Leuprorelin Acetate market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Leuprorelin Acetate market.
Geographical Analysis:
Based on region, the global Leuprorelin Acetate market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Leuprorelin Acetate market are
Merck
Takeda
MediGene
Livzon Pharmaceutical Group
Bejing Biote Pharmaceutical

Segment by Type
1.88 mg Preparation
2.75 mg Preparation
3.75 mg Preparation
Segment by Application
Hospital
Clinic
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Leuprorelin Acetate market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Leuprorelin Acetate market.
• The market share of the global Leuprorelin Acetate market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Leuprorelin Acetate market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Leuprorelin Acetate market.

レポート目次

1 Leuprorelin Acetate Market Overview
1.1 Leuprorelin Acetate Product Scope
1.2 Leuprorelin Acetate Segment by Type
1.2.1 Global Leuprorelin Acetate Sales by Type (2020-2026)
1.2.2 1.88 mg Preparation
1.2.3 2.75 mg Preparation
1.2.4 3.75 mg Preparation
1.3 Leuprorelin Acetate Segment by Application
1.3.1 Global Leuprorelin Acetate Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Leuprorelin Acetate Market Estimates and Forecasts (2015-2026)
1.4.1 Global Leuprorelin Acetate Sales Growth Rate (2015-2026)
1.4.2 Global Leuprorelin Acetate Revenue and Growth Rate (2015-2026)
1.4.3 Global Leuprorelin Acetate Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Leuprorelin Acetate Industry Impact
1.5.1 How the Covid-19 is Affecting the Leuprorelin Acetate Industry
1.5.1.1 Leuprorelin Acetate Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Leuprorelin Acetate Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Leuprorelin Acetate Players to Combat Covid-19 Impact

2 Leuprorelin Acetate Estimate and Forecast by Region
2.1 Global Leuprorelin Acetate Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Leuprorelin Acetate Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Leuprorelin Acetate Sales Market Share by Region (2015-2020)
2.2.2 Global Leuprorelin Acetate Revenue Market Share by Region (2015-2020)
2.3 Global Leuprorelin Acetate Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Leuprorelin Acetate Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Leuprorelin Acetate Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Leuprorelin Acetate Estimates and Projections (2015-2026)
2.4.2 Europe Leuprorelin Acetate Estimates and Projections (2015-2026)
2.4.3 China Leuprorelin Acetate Estimates and Projections (2015-2026)
2.4.4 Japan Leuprorelin Acetate Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Leuprorelin Acetate Estimates and Projections (2015-2026)
2.4.6 India Leuprorelin Acetate Estimates and Projections (2015-2026)
3 Global Leuprorelin Acetate Competition Landscape by Players
3.1 Global Top Leuprorelin Acetate Players by Sales (2015-2020)
3.2 Global Top Leuprorelin Acetate Players by Revenue (2015-2020)
3.3 Global Leuprorelin Acetate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leuprorelin Acetate as of 2019)
3.4 Global Leuprorelin Acetate Average Price by Company (2015-2020)
3.5 Manufacturers Leuprorelin Acetate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Leuprorelin Acetate Players (Opinion Leaders)
4 Global Leuprorelin Acetate Market Size by Type
4.1 Global Leuprorelin Acetate Historic Market Review by Type (2015-2020)
4.1.1 Global Leuprorelin Acetate Sales Market Share by Type (2015-2020)
4.1.2 Global Leuprorelin Acetate Revenue Market Share by Type (2015-2020)
4.1.3 Global Leuprorelin Acetate Price by Type (2014-2020)
4.2 Global Leuprorelin Acetate Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Leuprorelin Acetate Sales Forecast by Type (2021-2026)
4.2.2 Global Leuprorelin Acetate Revenue Forecast by Type (2021-2026)
4.2.3 Global Leuprorelin Acetate Price Forecast by Type (2021-2026)
5 Global Leuprorelin Acetate Market Size by Application
5.1 Global Leuprorelin Acetate Historic Market Review by Application (2015-2020)
5.1.1 Global Leuprorelin Acetate Sales Market Share by Application (2015-2020)
5.1.2 Global Leuprorelin Acetate Revenue Market Share by Application (2015-2020)
5.1.3 Global Leuprorelin Acetate Price by Application (2015-2020)
5.2 Global Leuprorelin Acetate Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Leuprorelin Acetate Sales Forecast by Application (2021-2026)
5.2.2 Global Leuprorelin Acetate Revenue Forecast by Application (2021-2026)
5.2.3 Global Leuprorelin Acetate Price Forecast by Application (2021-2026)

3 North America Leuprorelin Acetate Market Facts & Figures
3.2 North America Leuprorelin Acetate Sales Market Share by Company (2015-2020)
3.3 North America Leuprorelin Acetate Sales Market Share by Type (2015-2020)
3.4 North America Leuprorelin Acetate Sales Market Share by Application (2015-2020)

4 Europe Leuprorelin Acetate Market Facts & Figures
4.2 Europe Leuprorelin Acetate Sales Market Share by Company (2015-2020)
4.3 Europe Leuprorelin Acetate Sales Market Share by Type (2015-2020)
4.4 Europe Leuprorelin Acetate Sales Market Share by Application (2015-2020)

5 China Leuprorelin Acetate Market Facts & Figures
5.2 China Leuprorelin Acetate Sales Market Share by Company (2015-2020)
5.3 China Leuprorelin Acetate Sales Market Share by Type (2015-2020)
5.4 China Leuprorelin Acetate Sales Market Share by Application (2015-2020)

6 Japan Leuprorelin Acetate Market Facts & Figures
6.2 Japan Leuprorelin Acetate Sales Market Share by Company (2015-2020)
6.3 Japan Leuprorelin Acetate Sales Market Share by Type (2015-2020)
6.4 Japan Leuprorelin Acetate Sales Market Share by Application (2015-2020)

7 Southeast Asia Leuprorelin Acetate Market Facts & Figures
7.2 Southeast Asia Leuprorelin Acetate Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Leuprorelin Acetate Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Leuprorelin Acetate Sales Market Share by Application (2015-2020)

8 India Leuprorelin Acetate Market Facts & Figures
8.2 India Leuprorelin Acetate Sales Market Share by Company (2015-2020)
8.3 India Leuprorelin Acetate Sales Market Share by Type (2015-2020)
8.4 India Leuprorelin Acetate Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Leuprorelin Acetate Business
12.1 Merck
12.1.1 Merck Leuprorelin Acetate Corporation Information
12.1.2 Merck Leuprorelin Acetate Business Overview and Total Revenue
12.1.3 Merck Leuprorelin Acetate Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Leuprorelin Acetate Products Offered
12.1.5 Merck Recent Development
12.2 Takeda
12.2.1 Takeda Leuprorelin Acetate Corporation Information
12.2.2 Takeda Leuprorelin Acetate Business Overview and Total Revenue
12.2.3 Takeda Leuprorelin Acetate Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Takeda Leuprorelin Acetate Products Offered
12.2.5 Takeda Recent Development
12.3 MediGene
12.3.1 MediGene Leuprorelin Acetate Corporation Information
12.3.2 MediGene Leuprorelin Acetate Business Overview and Total Revenue
12.3.3 MediGene Leuprorelin Acetate Sales, Revenue and Gross Margin (2015-2020)
12.3.4 MediGene Leuprorelin Acetate Products Offered
12.3.5 MediGene Recent Development
12.4 Livzon Pharmaceutical Group
12.4.1 Livzon Pharmaceutical Group Leuprorelin Acetate Corporation Information
12.4.2 Livzon Pharmaceutical Group Leuprorelin Acetate Business Overview and Total Revenue
12.4.3 Livzon Pharmaceutical Group Leuprorelin Acetate Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Livzon Pharmaceutical Group Leuprorelin Acetate Products Offered
12.4.5 Livzon Pharmaceutical Group Recent Development
12.5 Bejing Biote Pharmaceutical
12.5.1 Bejing Biote Pharmaceutical Leuprorelin Acetate Corporation Information
12.5.2 Bejing Biote Pharmaceutical Leuprorelin Acetate Business Overview and Total Revenue
12.5.3 Bejing Biote Pharmaceutical Leuprorelin Acetate Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bejing Biote Pharmaceutical Leuprorelin Acetate Products Offered
12.5.5 Bejing Biote Pharmaceutical Recent Development

13 Leuprorelin Acetate Manufacturing Cost Analysis
13.1 Leuprorelin Acetate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Leuprorelin Acetate
13.4 Leuprorelin Acetate Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Leuprorelin Acetate Distributors List
14.3 Leuprorelin Acetate Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Leuprorelin Acetate Sales (Tons) Growth Rate by Type (2020-2026)
Table 2. Global Leuprorelin Acetate Sales (Tons) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Leuprorelin Acetate Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Leuprorelin Acetate Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Leuprorelin Acetate Players to Combat Covid-19 Impact
Table 8. Global Market Leuprorelin Acetate Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Leuprorelin Acetate Sales (Tons) by Region (2015-2020)
Table 10. Global Leuprorelin Acetate Sales Market Share by Region (2015-2020)
Table 11. Global Leuprorelin Acetate Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Leuprorelin Acetate Revenue Share by Region (2015-2020)
Table 13. Global Leuprorelin Acetate Sales (Tons) Forecast by Region (2021-2026)
Table 14. Global Leuprorelin Acetate Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Leuprorelin Acetate Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Leuprorelin Acetate Revenue Share Forecast by Region (2021-2026)
Table 17. Global Leuprorelin Acetate (Tons) of Key Companies (2015-2020)
Table 18. Global Leuprorelin Acetate Sales Share by Company (2015-2020)
Table 19. Global Leuprorelin Acetate Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Leuprorelin Acetate Revenue Share by Company (2015-2020)
Table 21. Global Leuprorelin Acetate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leuprorelin Acetate as of 2019)
Table 22. Global Leuprorelin Acetate Average Price (US$/Ton) of Key Company (2015-2020)
Table 23. Manufacturers Leuprorelin Acetate Manufacturing Sites and Area Served
Table 24. Manufacturers Leuprorelin Acetate Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Leuprorelin Acetate Players
Table 27. Global Leuprorelin Acetate Sales (Tons) by Type (2015-2020)
Table 28. Global Leuprorelin Acetate Sales Share by Type (2015-2020)
Table 29. Global Leuprorelin Acetate Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Leuprorelin Acetate Price (Tons) by Type (2015-2020)
Table 31. Global Leuprorelin Acetate Sales Share by Type (2021-2026)
Table 32. Global Leuprorelin Acetate Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Leuprorelin Acetate Revenue Share by Type (2021-2026)
Table 34. Global Leuprorelin Acetate Price (Tons) by Type (2021-2026)
Table 35. Global Leuprorelin Acetate Sales (Tons) by Application (2015-2020)
Table 36. Global Leuprorelin Acetate Sales Share by Application (2015-2020)
Table 37. Global Leuprorelin Acetate Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Leuprorelin Acetate Price (Tons) by Application (2015-2020)
Table 39. Global Leuprorelin Acetate Sales (Tons) by Application (2021-2026)
Table 40. Global Leuprorelin Acetate Sales Share by Application (2021-2026)
Table 41. Global Leuprorelin Acetate Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Leuprorelin Acetate Revenue Share by Application (2021-2026)
Table 43. Global Leuprorelin Acetate Price (Tons) by Application (2021-2026)
Table 44. United States Leuprorelin Acetate Sales (Tons) by Company (2015-2020)
Table 45. United States Leuprorelin Acetate Sales Market Share by Company (2015-2020)
Table 46. United States Leuprorelin Acetate Sales (Tons) by Type (2015-2020)
Table 47. United States Leuprorelin Acetate Sales Market Share by Type (2015-2020)
Table 48. United States Leuprorelin Acetate Sales (Tons) by Application (2015-2020)
Table 49. United States Leuprorelin Acetate Sales Market Share by Application (2015-2020)
Table 50. Europe Leuprorelin Acetate Sales (Tons) by Company (2015-2020)
Table 51. Europe Leuprorelin Acetate Sales Market Share by Company (2015-2020)
Table 52. Europe Leuprorelin Acetate Sales (Tons) by Type (2015-2020)
Table 53. Europe Leuprorelin Acetate Sales Market Share by Type (2015-2020)
Table 54. Europe Leuprorelin Acetate Sales (Tons) by Application (2015-2020)
Table 55. Europe Leuprorelin Acetate Sales Market Share by Type (2015-2020)
Table 56. China Leuprorelin Acetate Sales (Tons) by Company (2015-2020)
Table 57. China Leuprorelin Acetate Sales Market Share by Company (2015-2020)
Table 58. China Leuprorelin Acetate Sales (Tons) by Type (2015-2020)
Table 59. China Leuprorelin Acetate Sales Market Share by Type (2015-2020)
Table 60. China Leuprorelin Acetate Sales (Tons) by Application (2015-2020)
Table 61. China Leuprorelin Acetate Sales Market Share by Application (2015-2020)
Table 62. Japan Leuprorelin Acetate Sales (Tons) by Company (2015-2020)
Table 63. Japan Leuprorelin Acetate Sales Market Share by Company (2015-2020)
Table 64. Japan Leuprorelin Acetate Sales (Tons) by Type (2015-2020)
Table 65. Japan Leuprorelin Acetate Sales Market Share by Type (2015-2020)
Table 66. Japan Leuprorelin Acetate Sales (Tons) by Application (2015-2020)
Table 67. Japan Leuprorelin Acetate Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Leuprorelin Acetate Sales (Tons) by Company (2015-2020)
Table 69. Southeast Asia Leuprorelin Acetate Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Leuprorelin Acetate Sales (Tons) by Type (2015-2020)
Table 71. Southeast Asia Leuprorelin Acetate Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Leuprorelin Acetate Sales (Tons) by Type (2015-2020)
Table 73. Southeast Asia Leuprorelin Acetate Sales Market Share by Application (2015-2020)
Table 74. India Leuprorelin Acetate Sales (Tons) by Company (2015-2020)
Table 75. India Leuprorelin Acetate Sales Market Share by Company (2015-2020)
Table 76. India Leuprorelin Acetate Sales (Tons) by Type (2015-2020)
Table 77. India Leuprorelin Acetate Sales Market Share by Type (2015-2020)
Table 78. India Leuprorelin Acetate Sales (Tons) by Application (2015-2020)
Table 79. India Leuprorelin Acetate Sales Market Share by Application (2015-2020)
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Leuprorelin Acetate Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 83. Merck Leuprorelin Acetate Product
Table 84. Merck Recent Development
Table 85. Takeda Corporation Information
Table 86. Takeda Description and Business Overview
Table 87. Takeda Leuprorelin Acetate Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 88. Takeda Leuprorelin Acetate Product
Table 89. Takeda Recent Development
Table 90. MediGene Corporation Information
Table 91. MediGene Description and Business Overview
Table 92. MediGene Leuprorelin Acetate Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 93. MediGene Leuprorelin Acetate Product
Table 94. MediGene Recent Development
Table 95. Livzon Pharmaceutical Group Corporation Information
Table 96. Livzon Pharmaceutical Group Description and Business Overview
Table 97. Livzon Pharmaceutical Group Leuprorelin Acetate Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 98. Livzon Pharmaceutical Group Leuprorelin Acetate Product
Table 99. Livzon Pharmaceutical Group Recent Development
Table . Bejing Biote Pharmaceutical Corporation Information
Table . Bejing Biote Pharmaceutical Description and Business Overview
Table . Bejing Biote Pharmaceutical Leuprorelin Acetate Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table . Bejing Biote Pharmaceutical Leuprorelin Acetate Product
Table . Bejing Biote Pharmaceutical Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Leuprorelin Acetate Distributors List
Table 108. Leuprorelin Acetate Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Leuprorelin Acetate Product Picture
Figure 2. Global Leuprorelin Acetate Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Leuprorelin Acetate Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Leuprorelin Acetate Sales (Tons) Growth Rate (2015-2026)
Figure 10. Global Leuprorelin Acetate Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Leuprorelin Acetate Price Trends Growth Rate (2015-2026) (US$/Ton)
Figure 12. Global Leuprorelin Acetate Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Leuprorelin Acetate Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Leuprorelin Acetate Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Leuprorelin Acetate Sales (Tons) Growth Rate (2015-2026)
Figure 16. Europe Leuprorelin Acetate Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Leuprorelin Acetate Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Leuprorelin Acetate Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Leuprorelin Acetate Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Leuprorelin Acetate Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Leuprorelin Acetate Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Leuprorelin Acetate Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Leuprorelin Acetate Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Leuprorelin Acetate Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Leuprorelin Acetate Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Leuprorelin Acetate Players Market Share by Revenue in Leuprorelin Acetate 2015 & 2019
Figure 27. Leuprorelin Acetate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Leuprorelin Acetate Revenue Share by Type (2015-2020)
Figure 29. Global Leuprorelin Acetate Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Leuprorelin Acetate Revenue Share by Application (2015-2020)
Figure 31. Global Leuprorelin Acetate Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Leuprorelin Acetate Sales Market Share by Type in 2019
Figure 33. United States Leuprorelin Acetate Sales Market Share by Type in 2019
Figure 34. Europe Leuprorelin Acetate Sales Market Share by Company in 2019
Figure 35. Europe Leuprorelin Acetate Sales Market Share by Type in 2019
Figure 36. Europe Leuprorelin Acetate Sales Market Share by Application in 2019
Figure 37. China Leuprorelin Acetate Sales Market Share by Company in 2019
Figure 38. China Leuprorelin Acetate Sales Market Share by Type in 2019
Figure 39. China Leuprorelin Acetate Sales Market Share by Application in 2019
Figure 40. Japan Leuprorelin Acetate Sales Market Share by Company in 2019
Figure 41. Japan Leuprorelin Acetate Sales Market Share by Type in 2019
Figure 42. Japan Leuprorelin Acetate Sales Market Share by Application in 2019
Figure 43. Southeast Asia Leuprorelin Acetate Sales Market Share by Company in 2019
Figure 44. Southeast Asia Leuprorelin Acetate Sales Market Share by Type in 2019
Figure 45. Southeast Asia Leuprorelin Acetate Sales Market Share by Application in 2019
Figure 46. India Leuprorelin Acetate Sales Market Share by Company in 2019
Figure 47. India Leuprorelin Acetate Sales Market Share by Type in 2019
Figure 48. India Leuprorelin Acetate Sales Market Share by Application in 2019
Figure 49. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. MediGene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Livzon Pharmaceutical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bejing Biote Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Leuprorelin Acetate
Figure 56. Manufacturing Process Analysis of Leuprorelin Acetate
Figure 57. Leuprorelin Acetate Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed